EP3958888 - SLOW-RELEASE CYTOKINE CONJUGATES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 28.01.2022 Database last updated on 14.06.2024 | |
Former | The international publication has been made Status updated on 31.10.2020 | Most recent event Tooltip | 12.04.2024 | New entry: Decision on request for further processing | Applicant(s) | For all designated states Prolynx LLC 455 Mission Bay Blvd. South Suite 145 San Francisco, CA 94158 / US | [2022/09] | Inventor(s) | 01 /
HANGASKY, John A. III 55 Trumbull Street, Apt. 2 San Francisco, California 94112 / US | 02 /
PFAFF, Samuel J. 3090 24th Avenue San Francisco, California 94132 / US | 03 /
SANTI, Daniel V. 211 Belgrave San Francisco, California 94117 / US | [2022/09] | Representative(s) | V.O. P.O. Box 87930 2508 DH Den Haag / NL | [2022/09] | Application number, filing date | 20795140.1 | 24.04.2020 | [2022/09] | WO2020US29911 | Priority number, date | US201962839112P | 26.04.2019 Original published format: US 201962839112 P | [2022/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020219943 | Date: | 29.10.2020 | Language: | EN | [2020/44] | Type: | A1 Application with search report | No.: | EP3958888 | Date: | 02.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.10.2020 takes the place of the publication of the European patent application. | [2022/09] | Search report(s) | International search report - published on: | US | 29.10.2020 | (Supplementary) European search report - dispatched on: | EP | 13.06.2023 | Classification | IPC: | A61K38/20, C07K14/55, C12N15/26 | [2022/09] | CPC: |
C07K14/47 (EP,KR);
A61K47/60 (EP,KR,US);
A61K47/6903 (EP,KR,US);
A61K38/19 (KR,US);
A61K38/2013 (KR,US);
A61K47/6925 (EP,KR,US);
A61P19/02 (EP);
A61P25/00 (EP,KR);
A61P29/00 (EP,KR);
C07K14/55 (EP,KR);
A61K38/00 (EP,KR);
A61P37/02 (US);
C07K2319/50 (EP,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/09] | Title | German: | CYTOKINKONJUGATE MIT LANGSAMER FREISETZUNG | [2022/09] | English: | SLOW-RELEASE CYTOKINE CONJUGATES | [2022/09] | French: | CONJUGUÉS DE CYTOKINE À LIBÉRATION LENTE | [2022/09] | Entry into regional phase | 13.10.2021 | National basic fee paid | 13.10.2021 | Search fee paid | 13.10.2021 | Designation fee(s) paid | 13.10.2021 | Examination fee paid | Examination procedure | 13.10.2021 | Examination requested [2022/09] | 31.01.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 28.03.2024 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 28.03.2024 | Request for further processing filed | 28.03.2024 | Full payment received (date of receipt of payment) Request granted | 11.04.2024 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 28.03.2024 | Request for further processing filed | 28.03.2024 | Full payment received (date of receipt of payment) Request granted | 11.04.2024 | Decision despatched | Fees paid | Renewal fee | 16.03.2022 | Renewal fee patent year 03 | 14.03.2023 | Renewal fee patent year 04 | 13.03.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2011140376 (PROLYNX LLC [US], et al) [Y] 1-14* Title; paragraph 2; at least claims 1, 18 *; | [Y] - JEFF HENISE ET AL, "Biodegradable Tetra-PEG Hydrogels as Carriers for a Releasable Drug Delivery System", BIOCONJUGATE CHEMISTRY, US, (20150113), vol. 26, no. 2, doi:10.1021/bc5005476, ISSN 1043-1802, pages 270 - 278, XP055637653 [Y] 1-14 * Title; Abstract; SCheme 1 * DOI: http://dx.doi.org/10.1021/bc5005476 | International search | [A]US8268773 (PRESNELL SCOTT R [US], et al) [A] 1-5, 12-18, 24* ; entire document *; | [XA]WO2015153753 (NEKTAR THERAPEUTICS [US]) [X] 1-3 * ; para [0049], [0081], [0088], [0109] * [A] 4-5, 12-18, 24; | [A]US2018250363 (LEE SEOJU [US], et al) [A] 1-5, 12-18, 24 * ; abstract, para [0008] *; | [A]US2018360977 (MCCAULEY SCOTT ALAN [US], et al) [A] 1-5, 12-18, 24 * ; entire document *; | [A]WO2019028419 (SYNTHORX INC [US]) [A] 1-5, 12-18, 24 * ; abstract, para [0005], [0030], [0036] * |